Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases

Carbohydrate Polymers

Volumn 136, Issue , 2016, Pages 1338-1347

  Rassu, Giovanna ^a   Salis, Andrea ^a   Porcu, Elena Piera ^b   Giunchedi, Paolo ^a   Roldo, Marta ^c   Gavini, Elisabetta ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Alginate; Chitosan; Composite hydrogel; Deferoxamine; Iron dysregulation diseases; PLGA microparticles

Indexed keywords

ALGINATE; AMINES; CHITIN; CHITOSAN; DRUG PRODUCTS; IRON; MICROSPHERES; ORGANIC POLYMERS;

COMPOSITE HYDROGELS; DEFEROXAMINE; PLGA MICROPARTICLES; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); POLY(D ,LLACTIDE-CO-GLYCOLIDE) MICROSPHERES; PREPARATION METHOD; SUSTAINED DRUG RELEASE; WATER SOLUBLE DRUGS;

HYDROGELS;

ALGINIC ACID; CHITOSAN; DEFEROXAMINE; DELAYED RELEASE FORMULATION; DRUG CARRIER; GLUCURONIC ACID; HEXURONIC ACID; HYDROGEL; IRON; LACTIC ACID; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG RELEASE; HYDROGEL; MEDICINAL CHEMISTRY; METABOLIC DISEASES; METABOLISM; PARTICLE SIZE; POROSITY; VISCOSITY;

ALGINATES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DEFEROXAMINE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG LIBERATION; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGELS; IRON; LACTIC ACID; METABOLIC DISEASES; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POROSITY; VISCOSITY;

EID: 84946136990     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2015.10.048     Document Type: Article

References (41)

1. P. Allain, Y. Mauras, D. Chaleil, P. Simon, K.S. Ang, G. Cam, and et al. Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis British Journal of Clinical Pharmacology 24 1987 207 212
2. M. Angel, K. Narayanan, W. Swartz, S.S. Ramasastry, D.B. Kuhns, R.E. Basford, and et al. Deferoxamine increases skin flap survival: Additional evidence of free radical involvement in ischemic flap survival British Journal of Plastic Surgery 39 1986 469 472
3. G. Arora, K. Malik, I. Singh, S. Arora, and V. Rana Formulation and evaluation of controlled release matrix mucoadhesive tablets of domperidone using Salvia plebeian gum Journal of Advanced Pharmaceutical Technology & Research 2 2011 163 169
4. S.J. Buwalda, K.W. Boere, P.J. Dijkstra, J. Feijen, T. Vermonden, and W.E. Hennink Hydrogels in a historical perspective: From simple networks to smart materials Journal of Controlled Release 190 2014 254 273
5. E. Caló, and V.V. Khutoryanskiy Biomedical applications of hydrogels: A review of patents and commercial products European Polymer Journal 65 2015 252 267
6. C. Camaschella, and P. Strati Recent advances in iron metabolism and related disorders Internal and Emergency Medicine 5 2010 393 400
7. M.D. Cappellini, and P. Pattoneri Oral iron chelators Annual Review of Medicine 60 2009 25 38
8. D.D. Diaz, S.B. Freeman, J.F. Wilson, and G.S. Parker Hematomainduced flap necrosis and free radical scavengers Archives of Otolaryngology 118 1992 516 518
9. J.L. Drury, and D.J. Mooney Hydrogels for tissue engineering: Scaffold design variables and applications Biomaterials 24 2003 4337 4351
10. A.S. Farberg, D. Sarhaddi, A. Donneys, S.S. Deshpande, and S.R. Buchman Deferoxamine enhances bone regeneration in mandibular distraction osteogenesis Plastic and Reconstructive Surgery 133 2014 666 671
11. P.A. Felice, S. Ahsan, A. Donneys, S.S. Deshpande, N.S. Nelson, and S.R. Buchman Deferoxamine administration delivers translational optimization of distraction osteogenesis in the irradiated mandible Plastic and Reconstructive Surgery 132 2013 542e 548e
12. S. Freiberg, and X.X. Zhu Polymer microspheres for controlled drug release International Journal of Pharmaceutics 282 2004 1 18
13. E. Gavini, P. Chetoni, M. Cossu, M.G. Alvarez, M.F. Saettone, and P. Giunchedi PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: In vitro/in vivo studies European Journal of Pharmaceutics and Biopharmaceutics 57 2004 207 212
14. P. Giunchedi, M. Maestri, E. Gavini, P. Dionigi, and G. Rassu Transarterial chemoembolization of hepatocellular carcinoma - Agents and drugs: An overview. Part 2 Expert Opinion on Drug Delivery 10 2013 799 810
15. B.S. Grewal, B. Keller, P. Weinhold, and L.E. Dahners Evaluating effects of deferoxamine in a rat tibia critical bone defect model Journal of Orthopaedics 11 2014 5 9
16. P.E. Hallaway, J.W. Eaton, S.S. Panter, and B.E. Hedlund Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers Proceedings of the National Academy of Sciences of the United States of America 86 1989 10108 10112
17. M. Hartmann, M. Dentini, K.I. Draget, and G. Skjåk-Bræk Enzymatic modification of alginates with the mannuronan C-5 epimerase AlgE4 enhances their solubility at low pH Carbohydrate Polymers 63 2006 257 262
18. B.P. Hertzberg, J.B. Holt, R.D. Graff, S.R. Gilbert, and L.E. Dahners An evaluation of carrier agents for deferoxamine, an upregulator of vascular endothelial growth factor Journal of Biomaterials Applications 27 2013 1046 1054
19. T.R. Hoare, and D.S. Kohane Hydrogels in drug delivery: Progress and challenges Polymer 49 2008 1993 2007
20. D.B. Hom, G.S. Goding Jr., J.A. Price, K.J. Pernell, and R.H. Maisel The effects of conjugated deferoxamine in porcine skin flaps Head & Neck 22 2000 579 584
21. Y. Hua, R.F. Keep, J.T. Hoff, and G. Xi Deferoxamine therapy for intracerebral haemorrhage Acta Neurochirurgica Supplement 105 2008 3 6
22. M. Imran ul-haq, J.L. Hamilton, B.F. Lai, R.A. Shenoi, S. Horte, I. Constantinescu, and et al. Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo ACS Nano 7 2013 10704 10716
23. H. Jin, S. Terai, and I. Sakaida The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis Journal of Gastroenterology 42 2007 475 484
24. K. Jomova, and M. Valko Importance of iron chelation in free radical-induced oxidative stress and human disease Current Pharmaceutical Design 17 2011 3460 3473
25. A. Loh, M. Hadziahmetovic, and J.L. Dunaief Iron homeostasis and eye disease Biochimica et Biophysica Acta 1790 2009 637 649
26. A.F. Mericli, A. Das, R. Best, P. Rodeheaver, G. Rodeheaver, and K.Y. Lin Deferoxamine mitigates radiation-induced tissue injury in a rat irradiated tram flap model Plastic & Reconstructive Surgery 135 2015 124e 134e
27. S.F. Morris, C.Y. Pang, N.M. Lofchy, G. Davidson, W.K. Lindsay, R.M. Zuker, and et al. Deferoxamine attenuates ischemia-induced reperfusion injury in the skin and muscle of myocutaneous flaps in the pig Plastic & Reconstructive Surgery 92 1993 120 132
28. A. Pouillot, A. Polla, and B.S. Polla Iron and iron chelators: A review on potential effects on skin aging Current Aging Science 6 2013 225 231
29. N.M. Ranjha, and U.F. Qureshi Preparation and characterization of crosslinked acrylic acid/hydroxypropyl methyl cellulose hydrogels for drug delivery International Journal of Pharmacy and Pharmaceutical Sciences 6 2014 400 410
30. G. Rassu, M. Nieddu, P. Bosi, P. Trevisi, M. Colombo, D. Priori, and et al. Encapsulation and modified-release of thymol from oral microparticles as adjuvant or substitute to current medications Phytomedicine 21 2014 1627 1632
31. G. Rassu, E. Soddu, M. Cossu, A. Brundu, G. Cerri, N. Marchetti, and et al. Solid microparticles based on chitosan or methyl-β-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate Journal of Controlled Release 201 2015 68 77
32. I. Sakaida, K. Hironaka, K. Uchida, and K. Okita Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient l-amino acid-defined diet in rats Digestive Diseases and Sciences 44 1999 560 569
33. A. Salis, G. Rassu, M. Budai-Szucs, I. Benzoni, E. Csányi, S. Berkó, and et al. Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: A preliminary study Expert Opinion on Drug Delivery 12 2015 1583 1596
34. K. Sollohub Spray drying technique. I: Hardware and process parameters Journal of Pharmaceutical Sciences 99 2009 575 587
35. A. Sosnik, and K.P. Seremeta Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers Advances in Colloid and Interface Science 223 2015 40 54
36. R. Stewart, J. Goldstein, A. Eberhardt, G.T. Chu, and S. Gilbert Increasing vascularity to improve healing of a segmental defect of the rat femur Journal of Orthopaedic Trauma 25 2011 472 476
37. G. Weinstein, M. Maves, and M. McCormack Deferoxamine decreases necrosis in dorsally based pig skin flaps Otolaryngology and Head and Neck Surgery 101 1989 559 561
38. T. Yamasaki, and I. Sakaida Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders Hepatology Research 42 2012 340 348
39. T. Yamasaki, S. Terai, and I. Sakaida Deferoxamine for advanced hepatocellular carcinoma The New England Journal of Medicine 365 2011 576 578
40. S. Zang, G. Dong, B. Peng, J. Xu, Z. Ma, X. Wang, and et al. A comparison of physicochemical properties of sterilized chitosan hydrogel and its applicability in a canine model of periodontal regeneration Carbohydrate Polymers 113 2014 240 248
41. W. Zhang, G. Li, R. Deng, L. Deng, and S. Qiu New bone formation in a true bone ceramic scaffold loaded with desferrioxamine in the treatment of segmental bone defect: A preliminary study Journal of Orthopaedic Science 17 2012 289 298